PFO
GH icon

Pathstone Family Office’s Guardant Health GH Stock Holding History

Pathstone Family Office’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-14,969
Closed -$806K – 1528
2022
Q3 		$806K Buy
+14,969
New +$768K 0.01% 851

Other funds holding GH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Pathstone Family Office's GH Position: Q4 2022 in Review

Pathstone Family Office sold out of Guardant Health (GH) in Q4 2022, closing a stake of 14,969 shares — an estimated $806K sold.

Pathstone Family Office first reported a position in GH in Q3 2022 and held it in 1 quarter. The position peaked at $806K in Q3 2022. 291 funds tracked by Wall St. Rank hold GH as of Q4 2022.

  • Pathstone Family Office reported no remaining Guardant Health position as of Q4 2022 after selling out during the quarter.
  • Pathstone Family Office sold 14,969 Guardant Health shares in Q4 2022, an estimated $806K.
  • Pathstone Family Office first reported a position in Guardant Health in Q3 2022 and held it in 1 quarter.
  • Pathstone Family Office's Guardant Health position peaked at $806K in Q3 2022.
  • 291 funds tracked by Wall St. Rank held Guardant Health as of Q4 2022.

Based on Pathstone Family Office's 13F filing for Q4 2022, filed 13 Feb 2023.